The Effect of High-Dose Insulin Analog Initiation Therapy on Lipid Peroxidation Products and Oxidative Stress Markers in Type 2 Diabetic Patients

Table 2

CGMS data of experimental groups.

Group	Mean blood glucose (mg/dL) before treatment	SD (mg/dL) before treatment	Mean blood glucose (mg/dl) after treatment	SD (mg/dL) after treatment
Insulin lispro mix (𝑛=8)	227.00 ± 65.91	67.25 ± 28.53	183.25 ± 77.09^a	39.38 ± 16.99^b
Insulin aspart (𝑛=8)	187.75 ± 51.17	45.88 ± 17.06	165.88 ± 50.08^a	32.50 ± 14.35^b
Insulin glargine (𝑛=8)	231.63 ± 30.87	38.75 ± 10.59	182.75 ± 32.85^a	32.25 ± 9.50^b

Data are mean ± SD. SD: standard deviation; ^a𝑃<0.05 compared to mean blood glucose before treatment within the same group; ^b𝑃<0.01 compared to SD before treatment within the same group.